Page 28 - Harvard Business Review, Sep/Oct 2018
P. 28

CONTINUED FROM PREVIOUS PAGE             In  Practice
        costs, thereby increasing profits without
        generating additional revenue. He points   SANJAY KHOSLA
        to one company where researchers
        focused on ways to increase food products’   “It’s very risky to bet
        shelf life. Still, he observes that companies
        operate under two distinctly different
        philosophies depending on the size of their   only on blockbusters”
        R&D budgets. “The motto of companies
        with big R&D budgets is ‘bigger, better,
        faster,’” he says, whereas companies     Sanjay Khosla spent more than 30 years   pineapple in the Middle East. It became
        with smaller R&D budgets “seem to do     as an executive at Unilever and Kraft,   entrepreneurial and nimble and looked
        extremely well by tweaking and improving   and now, as a senior adviser at Boston   not only at product innovations but also
        things in their brands and creating a lot   Consulting Group and a professor at   at design and packaging innovations,
        more sales.”                             Northwestern’s Kellogg School, he helps   supply chain innovations, and business
           The tension between the pursuit       companies find ways to increase organic   model innovations. Within five years
        of ambitious R&D efforts and more-       growth and improve their innovation   sales were above $1 billion. Following a
        incremental innovation isn’t new. In a   process. He spoke with HBR about   similar approach, Oreo went from sales of
        classic 2007 HBR article (“Is It Real? Can   balancing the pursuit of incremental   $200 million to sales of $1 billion outside
        We Win? Is It Worth Doing?: Managing Risk   innovations with more-ambitious   North America in six years.
        and Reward in an Innovation Portfolio”),   projects. Edited excerpts follow.
        Wharton professor George Day describes                                  How much are returns from innovation
        various methods companies can use to     What’s the main takeaway from this   limited by the culture inside large
        ensure the right balance of high-risk, high-  research? That companies that are   CPG firms? The biggest issue is not how
        reward innovations and safer, targeted   successful at innovation build on what’s   much firms spend or how they spend it; it’s
        ones. (He calls the two types Big I and   working. They look for what I call the 3Ms:   about the connections between functions.
        Little I innovations.) Interestingly, when he   areas with good profit margins, momentum,   At too many companies, R&D is looking
        surveyed the landscape a decade ago, he   and the potential to make a material   in the mirror at itself instead of looking out
        reached a conclusion opposite to the one   financial impact. They try to find a balance   the window at consumers. The scientists
        in the new research: that most companies   between quick wins and medium- and   are doing their own thing, without a focus
        were overinvesting in Little I innovations   long-term projects. It can’t be just about   on achieving commercial value. That’s
        and needed to pay more attention to      blockbusters, because it’s very risky to bet   one reason small companies are winning
        potential game changers.                 only on blockbusters.          market share. Big companies can still grow,
           Corstjens’s team notes that the different                            but they need to focus on categories where
        approaches to R&D are not only a function   When you ran Kraft’s developing   they can win, create cross-functional,
        of budget size; they also stem from culture.   markets businesses, what kinds of   entrepreneurial teams, and become far
        Among the firms in the study that favor   innovations were most successful at   more agile in their execution.
        smaller innovations, some have roots in   driving growth? Tang is an example. By
        the chemical or pharmaceutical industries,   2007 its sales outside the United States had   How is innovation changing inside
        where the R&D function typically enjoys   plateaued at about $500 million and begun   big CPG firms that, like Kraft Heinz,
        more power and respect than at CPG firms.   to slide. So we created a cross-functional   have been bought by private equity
        The researchers believe that in the latter,   team on which R&D and marketing and   firms? In the case of Kraft Heinz, the buyer,
        R&D is often overshadowed by marketing,   supply chain experts worked together   3G Capital, has a very different philosophy
        reducing the likelihood that spending on   and asked it to push sales to $700 million   and culture than most companies, so there
        it will translate to sales. “When R&D has   within five years. We gave it a blank   are a lot of changes. Many PE firms are
        a respected voice and collaborates with   check—lots of resources and autonomy,   highly successful at buying companies,
        marketing, firms have more success with   and encouragement to experiment and   cutting costs, and improving profitability.
        innovation,” they write.                 fail fast. It came up with new flavors,   I think the jury is still out as to whether
                            HBR Reprint F1805A   such as mango in the Philippines and   they can drive organic growth.
            ABOUT THE RESEARCH “Newton Versus
            Lorenz: Which Is the Better Model for
        Successful Innovation in Consumer Goods
        Companies?” by Marcel Corstjens, Gregory S.
        Carpenter, and Tushmit M. Hasan (MIT Sloan
        Management Review, forthcoming)




        24  HARVARD BUSINESS REVIEW SEPTEMBER–OCTOBER 2018
   23   24   25   26   27   28   29   30   31   32   33